Factors Associated with Lifetime HIV Testing in Texas by Race/Ethnicity

Introduction: In United States, roughly 1/5 of all HIV infected persons remain undiagnosed. Because HIV testing is critical to improve prevention efforts, more research is needed to understand the characteristics of individuals who get tested for HIV. Methods: This secondary analysis of the 2010 Texas Behavioral Risk Factor Surveillance System used data from 9,744 respondents between 18-64 years of age to evaluate the relationship between demographic characteristics (gender, race/ethnicity, age, area of residence, education, marital status, employment status, and income), healthcare characteristics (insurance status, having a primary provider, and access to healthcare), and HIV risk behaviors with ever having received an HIV test. Results: Significant associations between gender, age, area of residence, marital and employment status, and HIV risk behaviors and HIV testing in a Texas population by race/ethnicity were observed. Conclusions: These findings have important implications for future research into racial/ethnic disparities between lifetime HIV testing, and can help guide practitioners who work with populations at risk for HIV/AIDS in Texas.

Download Full-text

Older Women and HIV Testing: Examining the Relationship Between HIV Testing History, Age, and Lifetime HIV Risk Behaviors

Sexually Transmitted Diseases ◽

10.1097/olq.0b013e3181644b39 ◽

2008 ◽

Vol 35 (4) ◽

pp. 420-423 ◽

Cited By ~ 14

Author(s):

Aletha Y. Akers ◽

Lisa Bernstein ◽

Joyce Doyle ◽

Giselle Corbie-Smith

Keyword(s):

Hiv Testing ◽

Older Women ◽

Risk Behaviors ◽

Hiv Risk ◽

Hiv Risk Behaviors ◽

Women And Hiv ◽

The Relationship

Download Full-text

HIV Risk Behaviors, Previous HIV Testing and Positivity among Hispanic Women Tested for HIV in Florida, 2012

10.25148/etd.fidc001938 ◽

2017 ◽

Author(s):

Janelle Taveras

Keyword(s):

Hiv Testing ◽

Risk Behaviors ◽

Hiv Risk ◽

Hispanic Women ◽

Hiv Risk Behaviors

Download Full-text

Baseline Findings of an HIV Incidence Cohort Study to Prepare for Future HIV Prevention Clinical Trials in Kisumu, Kenya

The Journal of Infection in Developing Countries ◽

10.3855/jidc.2636 ◽

2012 ◽

Vol 6 (12) ◽

pp. 870-880 ◽

Cited By ~ 10

Author(s):

Wairimu Chege ◽

Sherri L Pals ◽

Eleanor McLellan-Lemal ◽

Sanjyot Shinde ◽

Monicah Nyambura ◽

...

Keyword(s):

Cohort Study ◽

Risk Behaviors ◽

Hiv Risk ◽

Hiv Risk Behaviors ◽

Hiv Prevalence ◽

Unprotected Sex ◽

Computer Assisted ◽

Hiv Incidence ◽

Field Station ◽

Hiv Test

Introduction: In an analysis of baseline findings of an HIV incidence cohort study, an assessment was made of HIV prevalence among persons presenting for enrollment and any differences in demographic characteristics between persons not enrolled compared to those enrolled. We also described and compared HIV risk behaviors in males and females enrolled in the study. Methodology: A computer-assisted survey was administered to collect baseline demographic and HIV risk data from 1,277 men and women aged 18-34 years. Testing for HIV and other sexually transmitted infections (STI) was conducted. Out of 1,277 persons prescreened for eligibility, 625 were enrolled. Results: HIV prevalence of all persons who completed screening was 14.8% (females: 21.1%; males: 8.1%). The odds of being enrolled in the study were higher for persons 18-24 years compared to those 30-34 years of age [adjusted odds ratio (AOR)=2.18, CI=1.13, 4.21] and males compared to females [AOR=2.07, CI=1.43, 2.99]. Among those enrolled in the study, the most prevalent HIV risk behaviors were unprotected sex (49%), alcohol use (45%), and transactional sex (30%) in the last three months. Compared to females, a significantly greater proportion of males reported using any alcohol or recreational drug in the last three months, a history of oral sex, sex with partner other than a spouse or main partner, ever having a blood transfusion, ever being treated for an STI, and having knowledge of their last HIV test result.Conclusion: The Kisumu Field Station successfully recruited individuals with HIV risk characteristics for the HIV incidence cohort study.

Download Full-text

Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine

Addiction Science & Clinical Practice ◽

10.1186/s13722-019-0172-2 ◽

2019 ◽

Vol 14 (1) ◽

Cited By ~ 1

Author(s):

Thomas R. Blue ◽

Michael S. Gordon ◽

Robert P. Schwartz ◽

Kathryn Couvillion ◽

Frank J. Vocci ◽

...

Keyword(s):

Hiv Infection ◽

Risk Behaviors ◽

Hiv Risk ◽

Hiv Risk Behaviors ◽

Community Treatment ◽

Outcome Variable ◽

Future Research ◽

Opioid Use ◽

The Impact ◽

Release From Prison

Abstract Background It has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after release from prison poses a serious risk of HIV infection. Prison-initiated buprenorphine may help to reduce HIV infection given the association between opioid use and HIV-risk behaviors. Methods The present study is a secondary analysis of longitudinal data gathered from a randomized controlled trial of buprenorphine-naloxone for people who were incarcerated (N = 211) between 2008 and 2012. It compares the impact of assignment to initiate buprenorphine in prison (N = 106 randomized, N = 104 analyzed) versus in the community (N = 107 randomized, N = 107 analyzed) and whether or not participants entered community treatment on the frequency of HIV-risk behaviors in the 12 months following release from prison. Data were analyzed hierarchically and for each outcome variable, a multilevel, over-dispersed Poisson model was fit to the data. Outcome variables were the number of times the following behaviors occurred in the last 30 days: (1) having sex without a condom (2) injecting drugs (3) using unsterilized needles, and (4) sharing injection paraphernalia. Results Participants assigned to begin buprenorphine in the community experienced a greater decrease in injection drug use over time compared to participants assigned to begin buprenorphine in prison. There were no significant associations between treatment assignment or community treatment entry and instances of having sex without a condom, sharing injection paraphernalia, or using unsterilized needles. Conclusions Overall, the present study did not find support for the initiation of buprenorphine in prison (as opposed to the community) as a means to reduce incidences of HIV-risk behaviors. Avenues for future research in the nexus of HIV-risk reduction, criminal justice, and pharmacotherapy are discussed. Trial registration This study was supported by the National Institute on Drug Abuse (NIDA), Buprenorphine for Prisoners (PI: Kinlock; R01DA021579). ClinicalTrials.gov identifier: NCT 00574067

Download Full-text